
Validea's guru fundamental report assessed ICON PLC (ICLR), a large-cap biotechnology stock, using Pim van Vliet's Multi-Factor Investor model, which targets low volatility, strong momentum, and high net payout yields. ICLR received a 50% rating, falling significantly short of the 80-90% threshold for investment interest within this strategy. While the stock passed market capitalization and standard deviation criteria, it was neutral on momentum and net payout yield, ultimately failing the model's final rank.
ICON PLC (ICLR), a large-cap biotechnology growth stock, was evaluated against Validea's Multi-Factor Investor model, which is based on Pim van Vliet's strategy of identifying low-volatility stocks with strong momentum and high net payout yields. The analysis revealed a mixed but ultimately unfavorable profile for ICLR under this specific framework. The company successfully passed the model's criteria for market capitalization and standard deviation, confirming its status as a low-volatility security. However, it failed to demonstrate the other key factors sought by the strategy, scoring as "NEUTRAL" on both its "Twelve Minus One Momentum" and its "Net Payout Yield." Consequently, ICLR received a final score of 50%, which is well below the 80% threshold for interest, leading to a "FAIL" on the model's final rank. The moderately negative sentiment score of -0.4 for the stock is consistent with this outcome, indicating that while it possesses desirable low-risk characteristics, its lack of strong momentum and shareholder returns makes it an unsuitable candidate for this particular factor-based investment approach.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately negative
Sentiment Score
-0.45
Ticker Sentiment